In the current context, exploring prognostic markers such as the antioxidant enzyme SOD could enhance the selection of effective therapy, intervention methods, monitoring of therapeutic strategies, and identification of tumor resistance to improve the survival of oral cancer patients. This evidence concerns the gene SOD1 and neoplasm.